Vimarsana
Biggest News Aggregation in the World

Natalie Staplin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Natalie Staplin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Natalie Staplin Today - Breaking & Trending Today

Tight Link Between Ambulatory BP and Mortality Affirmed in Revamped Analysis - Vimarsana News

Tight Link Between Ambulatory BP and Mortality Affirmed in Revamped Analysis

The study follows a prior one retracted due to data problems, with the information now “rescued for reliable analyses.”

Source: tctmd.com
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial - Vimarsana News

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

In patients hospitalised for COVID-19 with clinical hypoxia who required either no oxygen or simple oxygen only, higher dose corticosteroids significantly increased the risk of death compared with usual care, which included low-dose corticosteroids. The RECOVERY trial continues to assess the effects of higher dose corticosteroids in patients hospitalised with COVID-19 who require non-invasive ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation.

EMPA-Kidney Seals SGLT2 Inhibitors as 'Foundational' for CKD - Vimarsana News

EMPA-Kidney Seals SGLT2 Inhibitors as 'Foundational' for CKD

Empagliflozin's efficacy in a range of patients with chronic kidney disease in EMPA-Kidney filled evidence gaps and confirmed SGLT2 inhibitors as a key treatment regardless of diabetes status.